drugset / Trial / NCT01130636

Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation

NCT01130636

Phase 4 Completed 6 enrolled Pharmahungary Group Hoffmann-La Roche · collab
NaSingle-groupOpen-labelBasic science

Summary

The main purpose of this study is to assess the potential exposure of neonates to oseltamivir during lactation by examining oseltamivir concentrations in maternal blood, urine, and breast milk in breastfeeding women who are treated with oseltamivir, an anti-flu medication.

Timeline

Start
2010-06
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule 75 mg

Indications